公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis | Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN ; YEN-SHEN LU ; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. | BMC Medicine | 62 | 41 | |
2015 | Intra-Colonial Functional Differentiation-Related Modulation of the Cellular Membrane in a Pocilloporid Coral Seriatopora caliendrum | Tang C.-H.; Ku P.-C.; CHING-YU LIN ; Chen T.-H.; Lee K.-H.; Lee S.-H.; Wang W.-H. | Marine Biotechnology | 11 | 11 | |
2010 | Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method | Hsiao F.S.-H.; Cheng C.-C.; Peng S.-Y.; Huang H.-Y.; Lian W.-S.; Jan M.-L.; Fang Y.-T.; Cheng E.C.-H.; Lee K.-H.; Cheng W.T.-K.; Lin S.-P.; SHINN-CHIH WU ; SHAU-PING LIN | Cell Proliferation | 35 | 29 | |
2016 | Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods | Shiao C.-C.; Wu P.-C.; VIN-CENT WU ; Lin J.-H.; Pan H.-C.; Yang Y.-F.; TAI-SHUAN LAI ; TAO-MIN HUANG ; Wu C.-H.; WEI-SHUN YANG ; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; KUO-LIONG CHIEN ; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; KWAN-DUN WU ; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs) | Nephrology | 10 | 9 | |
2018 | Opsin gene expression regulated by testosterone level in a sexually dimorphic lizard | Tseng W.-H.; Lin J.-W.; Lou C.-H.; Lee K.-H.; LEANG-SHIN WU ; Wang T.-Y.; Wang F.-Y.; Irschick D.J.; Lin S.-M. | Scientific Reports | |||
2021 | Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial | Kudo M.; Lim H.Y.; ANN-LII CHENG ; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. | Liver Cancer | 30 | 26 | |
2020 | Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors | Desai J.; Deva S.; Lee J.S.; CHIA-CHI LIN ; Yen C.-J.; Chao Y.; Keam B.; Jameson M.; Hou M.-M.; Kang Y.-K.; Markman B.; Lu C.-H.; Rau K.-M.; Lee K.-H.; Horvath L.; Friedlander M.; Hill A.; Sandhu S.; Barlow P.; Wu C.-Y.; Zhang Y.; Liang L.; Wu J.; Paton V.; Millward M. | Journal for ImmunoTherapy of Cancer | 87 | 73 | |
2009 | Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-κB pathways | Lin J.-C.; Yang S.-C.; Hong T.-M.; SUNG-LIANG YU ; Qian S.; Linyi W.; Chen H.-Y.; PAN-CHYR YANG ; Lee K.-H. | Journal of Medicinal Chemistry | 54 | 51 | |
2012 | QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells | Chen M.-C.; Pan S.-L.; Shi Q.; Xiao Z.; Lee K.-H.; TSAI-KUN LI ; Teng C.-M. | Cancer Science | 15 | 13 | |
2002 | Reduction of human-to-pig cellular response by alteration of porcine MHC with human HLA DPW0401 exogenes | JANG-MING LEE ; Tu C.-F.; Yang P.-W.; Lee K.-H.; Tsuji K.; MENG-KUN TSAI ; Chen R.J.; CHUNG-YI HU ; Hsieh R.-P.; HAO-CHIH TAI ; BOR-LUEN CHIANG ; Weng C.-N.; Lee Y.-C.; Lee C.-J. | Transplantation | 12 | 11 | |
2020 | Response to Sung, Rosenberg, and Yang | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Yeo W.; Ueno T.; Li H.; Huang S.-M.; YEN-SHEN LU | Journal of the National Cancer Institute | 0 | 0 | |
2018 | Sexual and bladder dysfunction in male ketamine abusers: A large-scale questionnaire study | Yang S.S.-D.; Jang M.-Y.; Lee K.-H.; Hsu W.-T.; Chen Y.-C.; Chen W.-S.; SHANG-JEN CHANG | PLoS ONE | 16 | 13 | |
2000 | Successful generation of transgenic pigs for human decay-accelerating factor and human leucocyte antigen DQ | Tu C.-F.; Hsieh S.-L.; JANG-MING LEE ; Yang L.-L.; Sato T.; Lee K.-H.; Weng C.-N.; Mao S.J.T.; Tsuji K.; Lee C.-J. | Transplantation Proceedings | 12 | 10 | |
2011 | Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator | Lee K.-H.; Hsu E.-C.; JIH-HWA GUH ; Yang H.-C.; Wang D.; Kulp S.K.; Shapiro C.L.; Chen C.-S. | Journal of Biological Chemistry | 92 | 90 | |
2021 | Transgenerational effects of di(2-ethylhexyl) phthalate on anogenital distance, sperm functions and dna methylation in rat offspring | Hsu P.-C.; Jhong J.-Y.; Huang L.-P.; Lee K.-H.; Chen H.-P.; Yue Leon Guo | International Journal of Molecular Sciences | 14 | 12 | |
2019 | Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression | Yeo W.; Ueno T.; CHING-HUNG LIN ; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; YEN-SHEN LU ; The Asian Breast Cancer Cooperative Group | Breast Cancer Research and Treatment | 29 | 27 | |
2011 | A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways | Kuo T.-C.; Chiang P.-C.; Yu C.-C.; Nakagawa-Goto K.; Bastow K.F.; Lee K.-H.; JIH-HWA GUH | Biochemical Pharmacology | 18 | 15 |